DB18697ExperimentalProtein Based Therapies
RC88 is an antibody-drug conjugate comprising a humanized anti-mesothelin monoclonal antibody conjugated to monomethyl auristatin E (MMAE).
- Mechanism
- Curator reviewed
Pharmacologically active on Mesothelin
Resolves to
Targets
What you can answer from here — as of July 09, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with RC88, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account